Disc Medicine (IRON) Enterprise Value (2020 - 2026)

Disc Medicine (IRON) has 7 years of Enterprise Value data on file, last reported at -$730.2 million in Q1 2026.

• On a quarterly basis, Enterprise Value fell 5.11% year-over-year to -$730.2 million in Q1 2026; TTM through Mar 2026 was -$730.2 million, a 5.11% decrease from a year earlier, with the FY2025 full-year figure at -$791.2 million, down 61.5% from the prior year.
• Enterprise Value for Q1 2026 stood at -$730.2 million, up from -$791.2 million in the prior quarter.
• Over the last five years, Enterprise Value for IRON reached as high as -$101.7 million in Q3 2022 and fell as low as -$791.2 million in Q4 2025.
• Historically, Enterprise Value has averaged -$421.9 million across 5 years, with a median of -$377.6 million in 2023.
• Across the five-year window, Enterprise Value jumped 35.46% in 2022 and plunged 264.17% in 2023, its largest moves.
• Year by year, Enterprise Value stood at -$194.6 million in 2022, then sank by 85.18% to -$360.4 million in 2023, then plunged by 35.93% to -$489.9 million in 2024, then slumped by 61.5% to -$791.2 million in 2025, then climbed by 7.71% to -$730.2 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$730.2 million in Q1 2026, -$791.2 million in Q4 2025, and -$615.9 million in Q3 2025.